Principal of GMC Rajouri, Dr Amarjeet Singh Bhatia, told TNIE that the doctors at the hospital are now planning to reduce the Atropine doses for the patients. "All 11 patients undergoing treatment ...

The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for SYD-101 (atropine sulfate) to slow the progression of ...

Children with myopia using 0.05% atropine eye drops had less myopia progression and/or less axial elongation compared with ...

The FDA has set a PDUFA target action date of October 23, 2025, for the low-dose atropine formulation.